Correlation Between Femasys and Volitionrx
Can any of the company-specific risk be diversified away by investing in both Femasys and Volitionrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Femasys and Volitionrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Femasys and Volitionrx, you can compare the effects of market volatilities on Femasys and Volitionrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Femasys with a short position of Volitionrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Femasys and Volitionrx.
Diversification Opportunities for Femasys and Volitionrx
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Femasys and Volitionrx is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Femasys and Volitionrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Volitionrx and Femasys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Femasys are associated (or correlated) with Volitionrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Volitionrx has no effect on the direction of Femasys i.e., Femasys and Volitionrx go up and down completely randomly.
Pair Corralation between Femasys and Volitionrx
Given the investment horizon of 90 days Femasys is expected to generate 8.97 times less return on investment than Volitionrx. But when comparing it to its historical volatility, Femasys is 2.96 times less risky than Volitionrx. It trades about 0.03 of its potential returns per unit of risk. Volitionrx is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 58.00 in Volitionrx on October 20, 2024 and sell it today you would earn a total of 5.00 from holding Volitionrx or generate 8.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Femasys vs. Volitionrx
Performance |
| Timeline |
| Femasys |
| Volitionrx |
Femasys and Volitionrx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Femasys and Volitionrx
The main advantage of trading using opposite Femasys and Volitionrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Femasys position performs unexpectedly, Volitionrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Volitionrx will offset losses from the drop in Volitionrx's long position.| Femasys vs. Precision Optics, | Femasys vs. Repro Med Systems | Femasys vs. InfuSystems Holdings | Femasys vs. Utah Medical Products |
| Volitionrx vs. Electrocore LLC | Volitionrx vs. Evogene | Volitionrx vs. Evolus Inc | Volitionrx vs. OncoCyte Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |